title: Study of the correlation between clinical efficiency of impaza and serum ADMA level.
abstract: Correlation between superlow-dose antibodies to endothelial NO synthase (Impaza) and serum level of ADMA was evaluated in a double blind placebo-controlled study. The reduction of ADMA in patients with erectile dysfunction after impaza treatment was paralleled by improvement of clinical symptoms. No clear-cut correlation between ADMA level and impaza effect was detected.
authors.affiliation: nauka@materiamedica.ru
authors.forename: E S
authors.initials: ES
authors.lastname: Zhavbert
authors.forename: S A
authors.initials: SA
authors.lastname: Tarasov
authors.forename: J L
authors.initials: JL
authors.lastname: Dugina
authors.forename: S A
authors.initials: SA
authors.lastname: Sergeeva
authors.forename: S I
authors.initials: SI
authors.lastname: Gamidov
authors.forename: E B
authors.initials: EB
authors.lastname: Mazo
authors.forename: O I
authors.initials: OI
authors.lastname: Epstein
mesh_terms: D000328:Adult; D000906:Antibodies / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D004311:Double-Blind Method; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D052250:Nitric Oxide Synthase Type III / Q000276:immunology*
chemical_list: D000906:Antibodies; C018524:N,N-dimethylarginine; D001120:Arginine; D052250:Nitric Oxide Synthase Type III